Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shingo Kakihara
Observed names:
Kakihara Shingo,
S. Kakihara,
慎吾 柿原,
柿原慎吾
Institution:
University of Occupational and Environmental Health Japan
Observed institutions:
University of Occupational and Environmental Health Japan,
Japanese Society of Clinical Neuropsychopharmacology,
Hospital of the University of Occupational and Environmental Health
OpenAlex ID:
A5077801503
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6
2005
·
Shingo Kakihara
, Reiji Yoshimura
, et al.
·
International Clinical Psychopharmacology
·
95
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients
2007
·
Reiji Yoshimura
, Hikaru Hori
, et al.
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
58
Risperidone in the treatment of psychotic depression
2006
·
Makiko Goto
, Reiji Yoshimura
, et al.
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
36
An open study of risperidone liquid in the acute phase of schizophrenia
2005
·
Reiji Yoshimura
, Jun Nakamura
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
21
Effect of clonazepam treatment on antipsychotic drug‐induced Meige syndrome and changes in plasma levels of GABA, HVA, and MHPG during treatment
2001
·
Reiji Yoshimura
, Shingo Kakihara
, et al.
·
Psychiatry and Clinical Neurosciences
·
11
Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study
2008
·
Reiji Yoshimura
, Shingo Kakihara
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
10
Fluctuating plasma levels of the active moiety of risperidone is related to occurrence of extrapyramidal symptoms
2008
·
Reiji Yoshimura
, Nobuhisa Ueda
, et al.
·
International Journal of Psychiatry in Clinical Practice
·
9
Prediction of response to risperidone treatment with respect to plasma concentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6
2007
·
慎吾 柿原
·
9
Effects of olanzapine on plasma levels of monoamine metabolites and brain-derived neurotrophic factor in schizophrenic patients
2006
·
Hikaru Hori
, Reiji Yoshimura
, et al.
·
International Clinical Psychopharmacology
·
5
Little Effects of Low Dosage of Levomepromazine on Plasma Risperidone Levels
2005
·
R. Yoshimura
, K. Shinkai
, et al.
·
Pharmacopsychiatry
·
3
Social Adaptation Self-evaluation Scale(SASS)日本語版の信頼性および妥当性
2005
·
後藤牧子
, 上田展久
, et al.
·
精神医学
·
1
Polymorphisms of noradrenaline transporter are not associated with plasma levels of 3-methoxy-4-hydroxy-phenylethylene glycol and homovanillic acid or response to risperidone treatment in schizophrenic patients
2006
·
Reiji Yoshimura
, Takahiro Shinkai
, et al.
·
International Clinical Psychopharmacology
Effect of olanzapine on plasma monoamine metabolites in schizophrenic patients
2005
·
Yasuhisa Yamada
, Reiji Yoshimura
, et al.
·
International Clinical Psychopharmacology
Risperidone liquid improves positive symptoms of acute phase of schizophrenia by changing in plasma homovanillic acid levels
2005
·
Reiji Yoshimura
, Jun Nakamura
, et al.
·
International Clinical Psychopharmacology
Psychopharmacogenetical study with respect to paroxetine treatment
2005
·
Kyoko Kaji
, Reiji Yoshimura
, et al.
·
International Clinical Psychopharmacology
Risperidone in the treatment of delusional depression
2004
·
Makiko Goto
, Reiji Yoshimura
, et al.
·
International Clinical Psychopharmacology
Risperidone liquid is effective for patients with acute phase of schizophrenia
2004
·
Reiji Yoshimura
, Shingo Kakihara
, et al.
·
International Clinical Psychopharmacology
Small effects of low dosage levomepromazine on plasma risperidone levels in a steady state
2004
·
Reiji Yoshimura
, Koji Shinkai
, et al.
·
International Clinical Psychopharmacology
Psychopharmacogenetic study regarding risperidone in Japanese schizophrenic patients
2004
·
Shingo Kakihara
, Reiji Yoshimura
, et al.
·
International Clinical Psychopharmacology
Withdrawal syndrome associated with paroxetine
2003
·
Shingo Kakihara
, Nobuhisa Ueda
, et al.
·
International Clinical Psychopharmacology
Plasma concentrations of milnacipran and clinical effects
2003
·
Nobuhisa Ueda
, Koji Shinkai
, et al.
·
International Clinical Psychopharmacology
研修医を応援する-処方奏効・失敗例 水中毒後に横紋筋融解症と悪性症候群を呈したアスペルガー障害の1例
2003
·
Kakihara Shingo
, Yoshimura Reiji
·
臨床精神薬理
抗うつ薬を徹底比較する 抗うつ薬の棲み分け Snriの臨床的な位置づけ
2002
·
柿原慎吾
, 上田展久
, et al.
·
臨床精神薬理
Show more works
View as search
Works count:
23
Citation count:
258
H-index:
8
I10-index:
6
Year
Topic
Type